264 related articles for article (PubMed ID: 33356149)
1. Development of a Battery of
Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
[TBL] [Abstract][Full Text] [Related]
2. Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs.
Hong H; Thakkar S; Chen M; Tong W
Sci Rep; 2017 Dec; 7(1):17311. PubMed ID: 29229971
[TBL] [Abstract][Full Text] [Related]
3. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
[TBL] [Abstract][Full Text] [Related]
5. Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
Shimizu Y; Sasaki T; Takeshita JI; Watanabe M; Shizu R; Hosaka T; Yoshinari K
PLoS One; 2021; 16(6):e0253855. PubMed ID: 34170966
[TBL] [Abstract][Full Text] [Related]
6. Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk Potential.
Aleo MD; Shah F; Allen S; Barton HA; Costales C; Lazzaro S; Leung L; Nilson A; Obach RS; Rodrigues AD; Will Y
Chem Res Toxicol; 2020 Jan; 33(1):223-238. PubMed ID: 31532188
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity.
Thakkar S; Li T; Liu Z; Wu L; Roberts R; Tong W
Drug Discov Today; 2020 Jan; 25(1):201-208. PubMed ID: 31669330
[TBL] [Abstract][Full Text] [Related]
8. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
Zhu X; Kruhlak NL
Toxicology; 2014 Jul; 321():62-72. PubMed ID: 24721472
[TBL] [Abstract][Full Text] [Related]
9. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
[TBL] [Abstract][Full Text] [Related]
10. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Liu Z; Shi Q; Ding D; Kelly R; Fang H; Tong W
PLoS Comput Biol; 2011 Dec; 7(12):e1002310. PubMed ID: 22194678
[TBL] [Abstract][Full Text] [Related]
11. FDA-approved drug labeling for the study of drug-induced liver injury.
Chen M; Vijay V; Shi Q; Liu Z; Fang H; Tong W
Drug Discov Today; 2011 Aug; 16(15-16):697-703. PubMed ID: 21624500
[TBL] [Abstract][Full Text] [Related]
12. Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs.
Zhang H; Zhang HR; Hu ML; Qi HZ
J Pharmacol Toxicol Methods; 2022; 116():107185. PubMed ID: 35623583
[TBL] [Abstract][Full Text] [Related]
13. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury.
Chen M; Borlak J; Tong W
Hepatology; 2013 Jul; 58(1):388-96. PubMed ID: 23258593
[TBL] [Abstract][Full Text] [Related]
14. Ensemble Models Based on QuBiLS-MAS Features and Shallow Learning for the Prediction of Drug-Induced Liver Toxicity: Improving Deep Learning and Traditional Approaches.
Mora JR; Marrero-Ponce Y; García-Jacas CR; Suarez Causado A
Chem Res Toxicol; 2020 Jul; 33(7):1855-1873. PubMed ID: 32406679
[TBL] [Abstract][Full Text] [Related]
15. Prediction of drug induced liver injury using molecular and biological descriptors.
Muller C; Pekthong D; Alexandre E; Marcou G; Horvath D; Richert L; Varnek A
Comb Chem High Throughput Screen; 2015; 18(3):315-22. PubMed ID: 25747442
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
17. Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays.
Shah F; Leung L; Barton HA; Will Y; Rodrigues AD; Greene N; Aleo MD
Toxicol Sci; 2015 Oct; 147(2):500-14. PubMed ID: 26206150
[TBL] [Abstract][Full Text] [Related]
18. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
Lammert C; Einarsson S; Saha C; Niklasson A; Bjornsson E; Chalasani N
Hepatology; 2008 Jun; 47(6):2003-9. PubMed ID: 18454504
[TBL] [Abstract][Full Text] [Related]
19. Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure.
Liu A; Walter M; Wright P; Bartosik A; Dolciami D; Elbasir A; Yang H; Bender A
Biol Direct; 2021 Jan; 16(1):6. PubMed ID: 33461600
[TBL] [Abstract][Full Text] [Related]
20. In Silico Prediction of Drug-Induced Liver Injury Based on Ensemble Classifier Method.
Wang Y; Xiao Q; Chen P; Wang B
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
